Abstract
Abstract Snake envenoming is a partly solved threat that constitutes a major concern for the public health of tropical and subtropical countries. Antisera based in polyclonal heterologous antibodies save the victims’ life, but often are not efficient enough to avoid the amputation of the affected limbs. In this strategic approach we propose to complement the site-specific activity of the antisera by co administering special nanovesicles capable of adsorbing and thereby reducing the enzymatic activities responsible for neurotoxicity, pain, haemolysis, and fundamentally severe inflammation and myonecrosis, that end up in limbs ‘amputation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
